Does depression in mid-life predispose to greater cognitive decline in later life in the Whitehall II cohort?

Abstract

BackgroundLater-life depression appears to have different symptomatology and possibly underlying pathology to younger adults. Depression is linked to dementia but whether it is a risk factor or an early sign of dementia remains unclear. Neuroinflammation is increasingly recognised in both conditions. AimsTo investigate the link between depression, inflammation and dementia. We hypothesised that recurrent depression increases the rate of cognitive decline in older adults and that this effect is modified by anti-inflammatory medication. MethodsWe used data from Whitehall II including cognitive test results and reliable measures to assess depression. Depression was defined as a self-reported diagnosis or a score of ≥20 on the CESD. The presence/absence of inflammatory illness was assessed using a standardised list of inflammatory conditions. Individuals with dementia, chronic neurological and psychotic conditions were excluded.Logistic and linear regression was used to examine the effect of depression on cognitive test performance and the effect of chronic inflammation. LimitationsLack of clinical diagnoses of depression. ResultsThere were 1063 individuals with and 2572 without depression. Depression did not affect deterioration in episodic memory, verbal fluency or the AH4 test at 15-year follow up. We found no evidence of an effect of anti-inflammatory medication. Depressed individuals had worse cross-sectional performance on the Mill Hill test and tests of abstract reasoning and verbal fluency at both baseline and 15-year follow-up. ConclusionsUsing a UK based study with a long follow-up interval we have shown that depression in individuals aged >50 is not associated with increased cognitive decline.